Literature DB >> 4319950

Cancer chemotherapy--the first twenty-five years.

R B Scott.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4319950      PMCID: PMC1819834          DOI: 10.1136/bmj.4.5730.259

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  78 in total

1.  MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS.

Authors:  J H BROWN; B J KENNEDY
Journal:  N Engl J Med       Date:  1965-01-21       Impact factor: 91.245

2.  An evaluation of 5-fluorouracil in malignant disease.

Authors:  A J WEISS; L G JACKSON; R CARABASI
Journal:  Ann Intern Med       Date:  1961-11       Impact factor: 25.391

3.  The influence of cyclophosphamide upon neoplastic diseases in man.

Authors:  H HAAR; G J MARSHALL; H R BIERMAN; J L STEINFELD
Journal:  Cancer Chemother Rep       Date:  1960-02

4.  [Experimental bases of cancer chemotherapy; biochemical, pharmacological and histopathological studies with nitrogen mustard N-oxide].

Authors:  N BROCK
Journal:  Arzneimittelforschung       Date:  1957-12

5.  Advances in chemotherapy of cancer in man.

Authors:  S FARBER; D PINKEL; E M SEARS; R TOCH
Journal:  Adv Cancer Res       Date:  1956       Impact factor: 6.242

6.  The nitrogen mustard-like actions of 2,4,6-tris (ethylenimino)-s-triazine and other bis(ethylenimines).

Authors:  F S PHILIPS; J B THIERSCH
Journal:  J Pharmacol Exp Ther       Date:  1950-12       Impact factor: 4.030

7.  Mitomycin C therapy in advanced gastrointestinal cancer.

Authors:  C G Moertel; R J Reitemeier; R G Hahn
Journal:  JAMA       Date:  1968-06-17       Impact factor: 56.272

8.  Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia.

Authors:  H SHAY; C ZARAFONETIS; N SMITH; I WOLDOW; D C SUN
Journal:  AMA Arch Intern Med       Date:  1953-11

9.  Treatment of Hodgkin's granuloma, chronic lymphatic leukaemia, polycythaemia vera, and other reticuloses with triethylenethiophosphoramide.

Authors:  M C ISRAELS; B J LEONARD; J F WILKINSON
Journal:  Lancet       Date:  1956-11-17       Impact factor: 79.321

10.  Tumour growth and anti-mitotic action. The role of spontaneous cell losses.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

View more
  11 in total

1.  From bench to bedside: the growing use of translational research in cancer medicine.

Authors:  Erin M Goldblatt; Wen-Hwa Lee
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 2.  Targeting cancer metabolism: a therapeutic window opens.

Authors:  Matthew G Vander Heiden
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

3.  [Chemotherapy of cancer: the present status (author's transl)].

Authors:  R Gross
Journal:  Langenbecks Arch Chir       Date:  1975-11

Review 4.  Metabolomics in cancer research and emerging applications in clinical oncology.

Authors:  Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale
Journal:  CA Cancer J Clin       Date:  2021-05-13       Impact factor: 286.130

5.  Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand.

Authors:  Charity Wayua; Jyoti Roy; Karson S Putt; Philip S Low
Journal:  Mol Pharm       Date:  2015-06-16       Impact factor: 4.939

6.  Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.

Authors:  Marwa A Aziz; Rabah A T Serya; Deena S Lasheen; Amal Kamal Abdel-Aziz; Ahmed Esmat; Ahmed M Mansour; Abdel Nasser B Singab; Khaled A M Abouzid
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

Review 7.  Drug Development Against Metastatic Cancers.

Authors:  Chen Wang; Sui Huang
Journal:  Yale J Biol Med       Date:  2017-03-29

8.  Constraint based modeling of metabolism allows finding metabolic cancer hallmarks and identifying personalized therapeutic windows.

Authors:  Sergio Bordel
Journal:  Oncotarget       Date:  2018-04-13

9.  A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.

Authors:  Jayanta Bhattacharyya; Joseph J Bellucci; Isaac Weitzhandler; Jonathan R McDaniel; Ivan Spasojevic; Xinghai Li; Chao-Chieh Lin; Jen-Tsan Ashley Chi; Ashutosh Chilkoti
Journal:  Nat Commun       Date:  2015-08-04       Impact factor: 14.919

Review 10.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.